Mandatory disclosure of holding and notice of trade in IDEX Biometrics
Tranche 1 of the private placement amounted to 4,731,594 shares. As disclosed separately, Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, participated in the private placement and subscribed for 739,360 shares in Tranche 1.
In connection with the private placement, the manager of the private placement, IDEX Biometrics and Mr. Storbråten entered into a share lending agreement.
Mr. Storbråten has lent 4,731,594 shares, ISIN NO0013536078, in connection with the settlement of Tranche 1. The shares have been lent, not sold, and will be returned in due course.
After the subscription by Pinchcliffe and the temporary lending of shares, Mr. Storbråten and close relations hold 6,503,476 or 12,48% shares of the total outstanding shares and votes in IDEX Biometrics after completion of Tranche 1.
Contact personAnders Storbråten, CEO and CFO Tel: +47 4163 8582E-mail: ir@idexbiometrics.com
About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.
For more information, visit www.idexbiometrics.com
About this noticeThis notice was issued by Erling Svela, Vice president of finance, on 23 July 2025 at 11:50 CET on behalf of IDEX Biometrics ASA. The information about the lending shall be disclosed according to article 19 no. 3 of the EU Market Abuse Regulation (EU 596/2014). The information about shareholding shall be disclosed according to section 4-2 of the Norwegian Securities Trading Act (STA). The information is published in accordance with section 5‑12 of the Norwegian Securities Trading Act.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Bloomberg
2 hours ago
- Bloomberg
Novo Cuts Forecast After Weight-Loss Drug Sales Fall Short
Novo Nordisk A/S slashed its financial forecast in a surprise update that cited lagging sales of its weight-loss drug Wegovy, as the company loses ground to Eli Lilly & Co. in the obesity market. The shares plunged. Novo now sees this year's sales growing 8% to 14% and operating profit expanding 10% to 16%, based on constant exchange rates, according to an unscheduled release from the Danish drugmaker on Tuesday. That compares with its previous growth forecasts of as much as 21% and 24%, respectively.

Yahoo
4 hours ago
- Yahoo
UnitedHealth Group falls short of profit expectations and issues a weak outlook, sending shares down 4%
NEW YORK (AP) — UnitedHealth Group falls short of profit expectations and issues a weak outlook, sending shares down 4%. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Bloomberg
4 hours ago
- Bloomberg
IPhone-Maker Hon Hai's Share Trading Halted Ahead of Disclosures
Hon Hai Precision Industry Co. 's shares have been suspended from trading ahead of the disclosure of market-sensitive information, an unusual move that suggests an important announcement Wednesday. The world's largest assembler of Apple Inc. 's iPhones will apply for a resumption of trading after that disclosure, Taiwan's stock exchange said in a statement.